Composite Subretinal Implants May Lessen Vision Loss From AMD
THURSDAY, April 5, 2018 -- A composite implant, termed the California Project to Cure Blindness-Retinal Pigment Epithelium 1 (CPCB-RPE1), which consists of a polarized monolayer of human embryonic stem cell-derived RPE (hESC-RPE) on an ultrathin...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Blindness | Eyes | Opthalmology | Pharmaceuticals | Stem Cell Therapy | Stem Cells | Vitamin A